Cytodyn Inc (CYDY)

[Biotech Investor]

"The vaccine platform is the brainchild of a team of scientists at the OHSU Vaccine and Gene Therapy Institute, or VGTI, including Jay Nelson, Ph.D.; Klaus Frueh, Ph.D.; Scott Hansen, Ph.D.; and Louis J. Picker, M.D. The acquisition, which includes a merger with the OHSU startup TomegaVax Inc., is a critical step in translating a basic science concept pioneered at OHSU into a portfolio of commercial vaccines that have the potential to protect against and cure some of the world’s deadliest infectious diseases, including HIV, malaria, hepatitis B, papillomavirus and tuberculosis."